3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with naltrexone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, J; Hunter, JC; Singh, L; Vass, CA; Woodruff, GN | 1 |
| Derrick, BE; Do, VH; Martinez, CO; Martinez, JL | 1 |
2 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and naltrexone
| Article | Year |
|---|---|
The anticonvulsant action of CI-977, a selective kappa-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex.
Topics: Animals; Anticonvulsants; Benzofurans; Dizocilpine Maleate; In Vitro Techniques; Mice; Mice, Inbred Strains; Naltrexone; Piperazines; Pyrrolidines; Radioligand Assay; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, Opioid, kappa; Seizures; Stereoisomerism | 1990 |
Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo.
Topics: Animals; Dentate Gyrus; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Long-Term Potentiation; Male; Naltrexone; Narcotic Antagonists; Perforant Pathway; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin | 2002 |